Skip to main content
. 2020 Oct 7;3(10):e2015198. doi: 10.1001/jamanetworkopen.2020.15198

Table 1. Demographic Characteristics of Analytic Cohort.

Characteristic Patients, No. (%) P value
Nonexpansion state (n = 7521) Expansion state (n = 7811)
Age, mean (SD), y 59.0 (3.9) 59.1 (3.8) .12
Year of diagnosis
2010 1056 (14.0) 1029 (13.2) .007
2011 1035 (13.8) 1085 (13.9)
2012 995 (13.2) 1039 (13.3)
2013 1031 (13.7) 1061 (13.6)
2014 974 (13.0) 1164 (14.9)
2015 1125 (15.0) 1189 (15.2)
2016 1305 (17.4) 1244 (15.9)
State
Hawaii 0 500 (6.4) <.001
Iowa 0 1595 (20.4)
New Mexico 0 568 (7.3)
Utah 859 (11.4) 0
Georgia 4352 (57.9) 0
Kentucky 0 1581 (20.2)
Louisiana 2310 (30.7) 0
New Jersey 0 3567 (45.7)
Race/ethnicitya
Non-Hispanic <.001
White 3912 (52.1) 5532 (71.9)
Black 3352 (44.7) 1125 (14.6)
Hispanic/Latino 166 (2.2) 539 (7.0)
Other 78 (1.0) 494 (6.4)
Marital status
Single 1170 (15.6) 994 (12.7) <.001
Married or domestic partner 4518 (60.1) 5011 (64.2)
Separated, divorced, or widowed 992 (13.2) 902 (11.6)
Missing 841 (11.2) 904 (11.6)
Insurance statusb
Insured <.001
Private or Medicare 6094 (87.7) 6378 (91.1)
Medicaid 482 (6.9) 453 (6.5)
Uninsured 373 (5.4) 174 (2.5)
Tumor stagec
T1 4708 (62.6) 4228 (54.1) <.001
T2 1815 (24.1) 2285 (29.3)
T3-T4 163 (2.2) 222 (2.8)
PSA, ng/mL
<10.0 3886 (51.7) 4169 (53.4) .08
10.0-19.9 2327 (30.9) 2362 (30.2)
>20.0 1308 (17.4) 1280 (16.4)
Gleason Score on biopsyd
3 + 3 = 6; GG1 219 (2.9) 252 (3.2) .002
3 + 4 = 7; GG2 1384 (18.4) 1310 (16.8)
4 + 3 = 7; GG3 3031 (40.3) 3054 (39.1)
≥4 + 4 = 8; GG4-5 2887 (38.4) 3195 (40.9)

Abbreviations: GG, grade group; PSA, prostate-specific antigen.

SI conversion factor: To convert PSA to micrograms per liter, multiply by 1.0.

a

Missing in 134 cases.

b

Missing in 1378 cases.

c

Missing in 1911 cases.

d

Gleason Score represents the most common pattern plus the second most common pattern noted on biopsy.